Background Even though the lives of millions have been saved in the past decades, the
mortality rate in patients with drug-resistant tuberculosis is still high. Different factors are …

Objectives We aimed to assess the effect of second-line anti-TB treatment and determine
which drugs can achieve the greatest clinical benefit for DR-TB-HIV patients by comparing …

Abstract Background Despite the World Health Organization efforts to expand access to the
tuberculosis treatment, multidrug resistant tuberculosis (MDR-TB) remains a major threat …

Objectives: Existing evidence suggests that drug-resistant tuberculosis (DR-TB) remains a
huge public health threat in high-burden TB countries such as Ethiopia. The purpose of this …

Objective To study the risk factors and prediction models of multidrug resistance in patients
with tuberculosis and diabetes and those with a history of tuberculosis treatment. Methods A …

Despite the availability and implementation of well-known efficacious interventions for
tuberculosis treatment by the Ministry of Health, Uganda (MoH), treatment non-adherence …

To effectively manage MDR-TB and its co-morbidity with HIV/AIDS, proactive screening
programs are imperative. The review highlights the necessity of active follow-up strategies to …

Background Adherence is key to the treatment success of multi-drug resistant tuberculosis
(MDR-TB) and prevention of community transmission. Directly observed therapy (DOT) is the …

Background Drug resistant tuberculosis (DR-TB) continues to be a significant global public
health concern despite the availability of effective TB medicines. Equally, delayed DR-TB …

Introduction Tuberculosis (TB), currently has limited treatment options, and faces worldwide
threat of drug-resistance (DR). In 2022, the DR-TB prevalence in Cameroon was 1.4 …